Guggenheim Starts Orchard Therapeutics (ORTX) at Buy
Tweet
Share
E-mailGet Alerts ORTX Hot Sheet
Price: $16.70 --0%
Rating Summary:
6 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
6 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Guggenheim analyst Whitney Ljem initiates coverage on Orchard Therapeutics (NASDAQ: ORTX) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Orchard Therapeutics click here. For more ratings news on Orchard Therapeutics click here.
Shares of Orchard Therapeutics closed at $15.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
- Rodman & Renshaw Starts Neurogene (NGNE) at Buy, PT $70
- Lucid Capital Markets Starts Microbot Medical (MBOT) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
